Diefenbach, C, Kahl, BS, McMillan, A, Briones, J, Banerjee, L, Cordoba, R, Miall, F, Burke, JM, Hirata, J, Jiang, YW, Paulson, JN, Chang, YM, Musick, L, Abrisqueta, P. Polatuzumab vedotin plus obinutuzumab and lenalidomide in patients with relapsed or refractory follicular lymphoma: a cohort of a multicentre, single-arm, phase 1b/2 study. Lancet Haematology. 2021; 8(12)DOI:10.1016/S2352-3026(21)00311-2. PMID:34826412. IF:30.153(Q1/1D).

Wierda, WG, Allan, JN, Siddiqi, T, Kipps, TJ, Opat, S, Tedeschi, A, Badoux, XC, Kuss, BJ, Jackson, S, Moreno, C, Jacobs, R, Pagel, JM, Flinn, I, Pak, Y, Zhou, C, Szafer-Glusman, E, Ninomoto, J, Dean, JP, James, DF, Ghia, P, Tam, CS. Ibrutinib Plus Venetoclax for First-Line Treatment of Chronic Lymphocytic Leukemia: Primary Analysis Results From the Minimal Residual Disease Cohort of the Randomized Phase II CAPTIVATE Study. JOURNAL OF CLINICAL ONCOLOGY. 2021; 39(34)DOI:10.1200/JCO.21.00807. PMID:34618601. IF:50.739(Q1/1D).

Scholkmann, F, Fischer, JB, Frisk, LK, Delgado-Mederos, R, Mayos, M, Highton, D, Wolf, U, Wolf, M, Durduran, T. Influence of study design on effects of mask wearing on fMRI BOLD contrast and systemic physiology - A comment on Law et al. (2021). NEUROIMAGE. 2021; 244DOI:10.1016/j.neuroimage.2021.118549. PMID:34508896. IF:7.400(Q1/2D).

Guisado-Alonso, D, Edo, MC, Alarcon, PVE, Garcia-Sanchez, SM, Font, MA, Romo, LM, Marrero-Gonzalez, P, Mengual, JJ, Castrillo, L, Montull, C, Corominas, H, Gomez-Choco, M. Progression of Large Vessel Disease in Patients With Giant Cell Arteritis-Associated Ischemic Stroke: The Role of Vascular Imaging A Case Series. JCR-JOURNAL OF CLINICAL RHEUMATOLOGY. 2021; 27(8)DOI:10.1097/RHU.0000000000001498. PMID:32732523. IF:3.902(Q3/6D).